Literature DB >> 33229355

Zhikang Ye1, Ying Wang1, Luis Enrique Colunga-Lozano1, Manya Prasad1, Wimonchat Tangamornsuksan1, Bram Rochwerg1, Liang Yao1, Shahrzad Motaghi1, Rachel J Couban1, Maryam Ghadimi1, Malgorzata M Bala1, Huda Gomaa1, Fang Fang1, Yingqi Xiao1, Gordon H Guyatt2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33229355      PMCID: PMC7721260          DOI: 10.1503/cmaj.200645-f

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  77 in total

1.  Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia.

Authors:  Diego Viasus; José Ramón Paño-Pardo; Elisa Cordero; Antoni Campins; Francisco López-Medrano; Aroa Villoslada; Maria C Fariñas; Asunción Moreno; Jesús Rodríguez-Baño; José Antonio Oteo; Joaquín Martínez-Montauti; Julián Torre-Cisneros; Ferrán Segura; Jordi Carratalà
Journal:  J Infect       Date:  2011-02-03       Impact factor: 6.072

2.  Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.

Authors:  Marco Confalonieri; Rosario Urbino; Alfredo Potena; Marco Piattella; Piercarlo Parigi; Giacomo Puccio; Rossana Della Porta; Carbone Giorgio; Francesco Blasi; Reba Umberger; G Umberto Meduri
Journal:  Am J Respir Crit Care Med       Date:  2004-11-19       Impact factor: 21.405

3.  Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.

Authors:  Dominic Snijders; Johannes M A Daniels; Casper S de Graaff; Tjip S van der Werf; Wim G Boersma
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

4.  Risk factors associated with death among influenza A (H1N1) patients, Tamil Nadu, India, 2010.

Authors:  S R Balaganesakumar; M V Murhekar; K K Swamy; M R Kumar; P Manickam; Prt Pandian
Journal:  J Postgrad Med       Date:  2013 Jan-Mar       Impact factor: 1.476

5.  Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan.

Authors:  Koichiro Kudo; Jin Takasaki; Toshie Manabe; Hideko Uryu; Ritsuko Yamada; Emi Kuroda; Nobuyuki Kobayashi; Takeji Matsushita
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Carolina Garcia-Vidal; Núria Fernández-Sabé; Jordi Carratalà; Ana Fernández-Agüera; Mercè Corominas; Susana Padrones; Francesc Gudiol; Frederic Manresa
Journal:  Crit Care       Date:  2011-03-15       Impact factor: 9.097

7.  Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.

Authors:  Nelson Lee; K C Allen Chan; David S Hui; Enders K O Ng; Alan Wu; Rossa W K Chiu; Vincent W S Wong; Paul K S Chan; K T Wong; Eric Wong; C S Cockram; John S Tam; Joseph J Y Sung; Y M Dennis Lo
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

8.  The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

Authors:  Jesse W Delaney; Ruxandra Pinto; Jennifer Long; François Lamontagne; Neill K Adhikari; Anand Kumar; John C Marshall; Deborah J Cook; Philippe Jouvet; Niall D Ferguson; Donald Griesdale; Lisa D Burry; Karen E A Burns; Jamie Hutchison; Sangeeta Mehta; Kusum Menon; Robert A Fowler
Journal:  Crit Care       Date:  2016-03-30       Impact factor: 9.097

9.  Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis.

Authors:  Yuqing Zhou; Xiaofang Fu; Xiaoxiao Liu; Chenyang Huang; Guo Tian; Cheng Ding; Jie Wu; Lei Lan; Shigui Yang
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

10.  Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Authors:  Gerard Moreno; Alejandro Rodríguez; Luis F Reyes; Josep Gomez; Jordi Sole-Violan; Emili Díaz; María Bodí; Sandra Trefler; Juan Guardiola; Juan C Yébenes; Alex Soriano; José Garnacho-Montero; Lorenzo Socias; María Del Valle Ortíz; Eudald Correig; Judith Marín-Corral; Montserrat Vallverdú-Vidal; Marcos I Restrepo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Intensive Care Med       Date:  2018-08-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.